Pellicano F - Search Results

1

Quantitative proteomics analysis of BMS-214662 effects on CD34 positive cells from chronic myeloid leukaemia patients.

Balabanov S, Evans CA, Abraham SA, Pellicano F, Copland M, Walker MJ, Whetton AD, Holyoake TL. Balabanov S, et al. Among authors: pellicano f. Proteomics. 2013 Jan;13(1):153-68. doi: 10.1002/pmic.201200022. Proteomics. 2013. PMID: 23184491

2

The MEK inhibitor PD184352 enhances BMS-214662-induced apoptosis in CD34+ CML stem/progenitor cells.

Pellicano F, Simara P, Sinclair A, Helgason GV, Copland M, Grant S, Holyoake TL. Pellicano F, et al. Leukemia. 2011 Jul;25(7):1159-67. doi: 10.1038/leu.2011.67. Epub 2011 Apr 12. Leukemia. 2011. PMID: 21483442 Free PMC article.

3

Stem cells in chronic myeloid leukaemia.

Pellicano F, Holyoake TL. Pellicano F, et al. Cancer Biomark. 2007;3(4-5):183-91. doi: 10.3233/cbm-2007-34-503. Cancer Biomark. 2007. PMID: 17917148 Free article. Review. No abstract available.

4

BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergizes with tyrosine kinase inhibitors.

Copland M, Pellicano F, Richmond L, Allan EK, Hamilton A, Lee FY, Weinmann R, Holyoake TL. Copland M, et al. Among authors: pellicano f. Blood. 2008 Mar 1;111(5):2843-53. doi: 10.1182/blood-2007-09-112573. Epub 2007 Dec 21. Blood. 2008. PMID: 18156496 Free article.

5

BMS-214662 induces mitochondrial apoptosis in chronic myeloid leukemia (CML) stem/progenitor cells, including CD34+38- cells, through activation of protein kinase Cbeta.

Pellicano F, Copland M, Jorgensen HG, Mountford J, Leber B, Holyoake TL. Pellicano F, et al. Blood. 2009 Nov 5;114(19):4186-96. doi: 10.1182/blood-2009-05-219550. Epub 2009 Sep 8. Blood. 2009. PMID: 19738029 Free article.

6

In search of CML stem cells' deadly weakness.

Pellicano F, Sinclair A, Holyoake TL. Pellicano F, et al. Curr Hematol Malig Rep. 2011 Jun;6(2):82-7. doi: 10.1007/s11899-011-0085-y. Curr Hematol Malig Rep. 2011. PMID: 21373837 Review.

7

Assembling defenses against therapy-resistant leukemic stem cells: Bcl6 joins the ranks.

Pellicano F, Holyoake TL. Pellicano F, et al. J Exp Med. 2011 Oct 24;208(11):2155-8. doi: 10.1084/jem.20112087. J Exp Med. 2011. PMID: 22025499 Free PMC article. Review.

8

Autocrine TNF-α production supports CML stem and progenitor cell survival and enhances their proliferation.

Gallipoli P, Pellicano F, Morrison H, Laidlaw K, Allan EK, Bhatia R, Copland M, Jørgensen HG, Holyoake TL. Gallipoli P, et al. Among authors: pellicano f. Blood. 2013 Nov 7;122(19):3335-9. doi: 10.1182/blood-2013-02-485607. Epub 2013 Sep 16. Blood. 2013. PMID: 24041577 Free PMC article.

9

Concise review: cancer cells escape from oncogene addiction: understanding the mechanisms behind treatment failure for more effective targeting.

Pellicano F, Mukherjee L, Holyoake TL. Pellicano F, et al. Stem Cells. 2014 Jun;32(6):1373-9. doi: 10.1002/stem.1678. Stem Cells. 2014. PMID: 24520002 Review.

10

The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors.

Pellicano F, Scott MT, Helgason GV, Hopcroft LE, Allan EK, Aspinall-O'Dea M, Copland M, Pierce A, Huntly BJ, Whetton AD, Holyoake TL. Pellicano F, et al. Stem Cells. 2014 Sep;32(9):2324-37. doi: 10.1002/stem.1748. Stem Cells. 2014. PMID: 24806995 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters